Ignite Creation Date:
2025-12-24 @ 11:03 PM
Ignite Modification Date:
2026-02-24 @ 5:50 AM
Study NCT ID:
NCT06864169
Status:
RECRUITING
Last Update Posted:
2025-12-18
First Post:
2025-03-03
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of Raludotatug Deruxtecan (R-DXd) in People With Gastrointestinal Cancers (MK-5909-005)
Sponsor:
Merck Sharp & Dohme LLC
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2025-04-01
Start Date Type:
ACTUAL
Primary Completion Date:
2026-07-06
Primary Completion Date Type:
ESTIMATED
Completion Date:
2029-01-04
Completion Date Type:
ESTIMATED
First Submit Date:
2025-03-03
First Submit QC Date:
None
Study First Post Date:
2025-03-07
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-12-17
Last Update Post Date:
2025-12-18
Last Update Post Date Type:
ESTIMATED